LobbyingAytu Biopharma lobbying by quarter
Aytu Biopharma's latest lobbying report covers Q2 2026, at under $5,000. Its first report covers Q1 2023; the issues it reports most are Food Industry (Safety, Labeling, etc.) and Pharmacy.
Aytu Biopharma
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $0
- Last 4 quarters
- vs last quarter
- No record
- Q3 2026 against the quarter before
- First report
- Q1 2023
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q1 2023 | $0 | 1 |
| Q2 2023 | $0 | 1 |
| Q3 2023 | $10K | 1 |
| Q4 2023 | $10K | 1 |
| Q1 2024 | $10K | 1 |
| Q2 2024 | $0 | 1 |
| Q3 2024 | $0 | 1 |
| Q4 2024 | $0 | 1 |
| Q1 2025 | $0 | 1 |
| Q2 2025 | $0 | 1 |
| Q3 2025 | $0 | 1 |
| Q4 2025 | $0 | 1 |
| Q1 2026 | $0 | 1 |
| Q2 2026 | $0 | 1 |
| Q3 2026 | $0 | 0 |
By issue
- Food industry$15K · 5 reports
- Pharmacy$15K · 5 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- HOUSE OF REPRESENTATIVES5 reports
- SENATE5 reports
- Food & Drug Administration (FDA)3 reports
Firms it paid
| Firm | ||
|---|---|---|
| Dorsey & Whitney | $30K | 14 quarters |
Former officials lobbying for it
No lobbyist with a covered position.
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/21for Q2 | Dorsey & Whitney | Under $5,000 |
| 04/17for Q1 | Dorsey & Whitney | Under $5,000 |
| 01/20for Q4 2025 | Dorsey & Whitney | Under $5,000 |
| 25/10/20for Q3 2025 | Dorsey & Whitney | Under $5,000 |
| 25/07/21for Q2 2025 | Dorsey & Whitney | Under $5,000 |
| 25/04/21for Q1 2025 | Dorsey & Whitney | Under $5,000 |
| 25/01/21for Q4 2024 | Dorsey & Whitney | Under $5,000 |
| 24/10/21for Q3 2024 | Dorsey & Whitney | Under $5,000 |
| 24/07/22for Q2 2024 | Dorsey & Whitney | Under $5,000 |
| 24/04/20for Q1 2024 | Dorsey & Whitney | $10K |
| 24/01/22for Q4 2023 | Dorsey & Whitney | $10K |
| 23/10/20for Q3 2023 | Dorsey & Whitney | $10K |
| 23/07/20for Q2 2023 | Dorsey & Whitney | Under $5,000 |
| 23/04/19for Q1 2023 | Dorsey & Whitney | Under $5,000 |
| 23/02/08for Q1 2023 | Dorsey & Whitney | Under $5,000 |